# Abiochem Biotechnology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/abiochem-biotechnology-co

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: www.abiochem.cn
- Total disclosed funding: $124M
- Latest round: Series D (Jul 24, 2025)
- Investors on record: 9

## About

Founded in 2015 and based in Shanghai, China, Abiochem Biotechnology Co., Ltd. is a high-tech company that engages in the development of biocatalysis and synthetic biology processes based on genetic & enzyme engineering technologies to apply them in commercial scale production. In July 2025, Abiochem Biotechnology Co., Ltd. raised CNY 450 million in Series D funding from new investor Guotou Juli Investment Management.
The company provides biocatalysis and synthetic biology methods that are widely used in pharmaceuticals, health products, pesticides, and other fields, contributing to the promotion and development of green chemistry.
The company generates revenue through the research and development of biocatalysis, synthetic biology methods and offers other services for biocatalysis technologies.

## Funding rounds

- Series D, Jul 24, 2025, $63M — Guotou Juli Investment Management
- Series C, May 5, 2021, $47M — Temasek Holdings, CMB International Asset Management
- Series A, Nov 28, 2020 — Beyond Capital, Sharelink Capital, Huatai Zijin Investment, Langcheng Capital
- Series A, Apr 3, 2019, $15M — Beyond Capital, HighLight Capital, Addor Capital, Huatai Zijin Investment
- Angel, Jun 28, 2018 — HighLight Capital

## Investors

- HighLight Capital (https://capitalatlas.ai/funds/highlight-capital) — Angel, Series A
- Beyond Capital — Series A
- Addor Capital (https://capitalatlas.ai/funds/addor-capital) — Series A
- Huatai Zijin Investment (https://capitalatlas.ai/funds/huatai-zijin-investment) — Series A
- Sharelink Capital (https://capitalatlas.ai/funds/sharelink-capital) — Series A
- Langcheng Capital (https://capitalatlas.ai/funds/langcheng-capital) — Series A
- Temasek Holdings — Series C
- CMB International Asset Management (https://capitalatlas.ai/funds/cmb-international-asset-management) — Series C
- Guotou Juli Investment Management (https://capitalatlas.ai/funds/guotou-juli-investment-management) — Series D